Concepedia

S. J. Lee

SJ

Statistics

Publications

1

Citations

60

H-Index

1

Active since

2010

S. J. Lee is an author specializing in vegfr inhibitors, early stopping, and tyrosine kinase inhibitor therapy.

Publications per year

2010–2010

1

Publications

1

Final results of E2603: A double-blind, randomized phase III trial comparing carboplatin (C)/paclitaxel (P) with or without sorafenib (S) in metastatic melanoma.

K. T. Flaherty, S. J. Lee, Lynn M. Schuchter et al. · Journal of Clinical Oncology · 2010 · 60 citations

, , +15

1–1 of 1